Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market
Holding INBX?
Track your performance easily

Inhibrx Biosciences Inc (INBX) Ownership - Who Owns Inhibrx Biosciences Inc?

16 Followers

Inhibrx Biosciences Inc (INBX) Ownership Overview

26.98%5.95%0.66%6.90%59.51%
26.98% Insiders
0.66% Other Institutional Investors
6.90% ETFs
59.51% Public Companies and Individual Investors
The ownership structure of Inhibrx Biosciences Inc (INBX) stock is a mix of institutional, retail, and individual investors. Approximately 13.51% of the company’s stock is owned by Institutional Investors, 26.98% is owned by Insiders, and 59.51% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 07, 2024
xxxxxxxxxxxxx
$100005
Sep 16, 2024
Mark Lappe
Ceo,director
xxxxxxxxxxxxx
$629117
Sep 12, 2024
xxxxxxxxxxxxx
$99992
Sep 10, 2024
Mark Lappe
Ceo,director
xxxxxxxxxxxxx
$671150

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$15077248
Jun 30, 2024
xxxxxxxxxxxxx
$25331779

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,787,705Institution12.35%28,084,846
1,157,926Insider8.00%18,191,017
1,093,860Insider7.56%17,184,541
1,064,026Institution7.35%16,715,848
925,413Insider6.39%14,538,238
500,299Institution3.46%7,859,697
473,888Insider3.27%7,444,780
418,578Institution2.89%6,575,860
403,281Institution2.79%6,335,545
224,564Insider1.55%3,527,900

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
403,281Institution2.79%6,335,545
116,108Institution0.80%1,824,057
66,166Institution0.46%1,039,468
55,338Institution0.38%869,360
51,472Institution0.36%808,625
49,627Institution0.34%779,640
24,513Institution0.17%385,099
24,228Institution0.17%380,622
16,050Institution0.11%252,146
11,064Institution0.08%173,815

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
337,352Institution2.33%5,282,932
268,022Institution1.85%4,167,742
99,212Institution0.69%1,553,660
64,234Institution0.44%998,839
53,164Institution0.37%832,548
48,897Institution0.34%760,348
26,455Institution0.18%411,375
23,001Institution0.16%363,416
11,850Institution0.08%185,571
11,132Institution0.08%173,103

FAQ

Who Owns Inhibrx Biosciences Inc (INBX)?
According to the latest TipRanks data, approximately 0.66% of the company's stock is held by institutional investors, 26.98% is held by insiders, and 59.51% is held by retail investors.
    What percentage of Inhibrx Biosciences Inc (INBX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.66% of Inhibrx Biosciences Inc (INBX) stock is held by institutional investors.
      What percentage of Inhibrx Biosciences Inc (INBX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 59.51% of Inhibrx Biosciences Inc (INBX) stock is held by retail investors.
        Who owns the most shares of Inhibrx Biosciences Inc (INBX)?
        Andreas Halvorsen owns the most shares of Inhibrx Biosciences Inc (INBX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis